British Journal of Cancer - Table of Contents alert Volume 110 Issue 6

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 110, Issue 6 (1409-1680) Published online 18 March 2014 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics and Genomics Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe   Advertisement BEATSON INTERNATIONAL CANCER CONFERENCE Powering the Cancer Machine 6-9 July 2014, Glasgow, Scotland This meeting will focus on the rewiring of metabolic signals that is initiated by oncogenic signals, and the adaptability of the metabolic network in response to stress. Registration, payment and abstract submission here    Minireview Top Cancer and systemic inflammation: treat the tumour and treat the host C S D Roxburgh and D C McMillan Br J Cancer 2014 110: 1409-1412; advance online publication, February 18, 2014; 10.1038/bjc.2014.90 Abstract | Full Text Clinical Studies Top Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen S Giacchetti, R Porcher, J Lehmann-Che, A-S Hamy, A de Roquancourt, C Cuvier, P-H Cottu, P Bertheau, M Albiter, F Bouhidel, F Coussy, J-M Extra, M Marty, H de Thé and M Espié Br J Cancer 2014 110: 1413-1419; advance online publication, February 25, 2014; 10.1038/bjc.2014.81 Abstract | Full Text Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II–III breast cancer? A multicentre retrospective study (KROG 12-05) J M Noh, W Park, C-O Suh, K C Keum, Y B Kim, K H Shin, K Kim, E K Chie, S W Ha, S S Kim, S D Ahn, H S Shin, J H Kim, H-S Lee, N K Lee, S J Huh and D H Choi Br J Cancer 2014 110: 1420-1426; advance online publication, January 30, 2014; 10.1038/bjc.2014.26 Abstract | Full Text Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients C Posch, F Weihsengruber, K Bartsch, V Feichtenschlager, M Sanlorenzo, I Vujic, B Monshi, S Ortiz-Urda and K Rappersberger Br J Cancer 2014 110: 1427-1432; advance online publication, February 11, 2014; 10.1038/bjc.2014.62 Abstract | Full Text Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients Y Wang, T K Choueiri, J-L Lee, M-H Tan, S Y Rha, S A North, C K Kollmannsberger, D F McDermott and D Y C Heng Br J Cancer 2014 110: 1433-1437; advance online publication, February 18, 2014; 10.1038/bjc.2014.28 Abstract | Full Text Epidemiology and natural history of central venous access device use and infusion pump function in the NO16966 trial E Chu, D Haller, T Cartwright, C Twelves, J Cassidy, W Sun, M W Saif, E McKenna, S Lee and H-J Schmoll Br J Cancer 2014 110: 1438-1445; advance online publication, February 18, 2014; 10.1038/bjc.2014.74 Abstract | Full Text Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma S Lauttia, H Sihto, H Kavola, V Koljonen, T Böhling and H Joensuu Br J Cancer 2014 110: 1446-1455; advance online publication, February 4, 2014; 10.1038/bjc.2014.20 Abstract | Full Text Long-term outcome after local recurrence of soft tissue sarcoma: a retrospective analysis of factors predictive of survival in 135 patients with locally recurrent soft tissue sarcoma A Daigeler, I Zmarsly, T Hirsch, O Goertz, H-U Steinau, M Lehnhardt and K Harati Br J Cancer 2014 110: 1456-1464; advance online publication, January 30, 2014; 10.1038/bjc.2014.21 Abstract | Full Text Prognostic value of magnetic resonance imaging-detected cranial nerve invasion in nasopharyngeal carcinoma X Liu, L-Z Liu, Y-P Mao, L Chen, L-L Tang, G-Q Zhou, Y Sun, D Yue, A-H Lin, L Li and J Ma Br J Cancer 2014 110: 1465-1471; advance online publication, February 4, 2014; 10.1038/bjc.2014.27 Abstract | Full Text Translational Therapeutics Top Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets M M Wattenberg, A R Kwilas, S R Gameiro, A P Dicker and J W Hodge Br J Cancer 2014 110: 1472-1480; advance online publication, February 20, 2014; 10.1038/bjc.2014.79 Abstract | Full Text Anticancer effects of gemcitabine are enhanced by co-administered iRGD peptide in murine pancreatic cancer models that overexpressed neuropilin-1 Y Akashi, T Oda, Y Ohara, R Miyamoto, T Kurokawa, S Hashimoto, T Enomoto, K Yamada, M Satake and N Ohkohchi Br J Cancer 2014 110: 1481-1487; advance online publication, February 20, 2014; 10.1038/bjc.2014.49 Abstract | Full Text Delayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell death I Obiorah, S Sengupta, P Fan and V C Jordan Br J Cancer 2014 110: 1488-1496; advance online publication, February 18, 2014; 10.1038/bjc.2014.50 Abstract | Full Text Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states T Yoshida, Y Ozawa, T Kimura, Y Sato, G Kuznetsov, S Xu, M Uesugi, S Agoulnik, N Taylor, Y Funahashi and J Matsui Br J Cancer 2014 110: 1497-1505; advance online publication, February 25, 2014; 10.1038/bjc.2014.80 Abstract | Full Text Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate F Khanim, N Davies, P Veliça, R Hayden, J Ride, C Pararasa, M G Chong, U Gunther, N Veerapen, P Winn, R Farmer, E Trivier, L Rigoreau, M Drayson and C Bunce Br J Cancer 2014 110: 1506-1516; advance online publication, February 25, 2014; 10.1038/bjc.2014.83 Abstract | Full Text Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients M Wilbaux, E Hénin, A Oza, O Colomban, E Pujade-Lauraine, G Freyer, M Tod and B You Br J Cancer 2014 110: 1517-1524; advance online publication, February 20, 2014; 10.1038/bjc.2014.75 Abstract | Full Text Molecular Diagnostics Top Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas G H Bain, E Collie-Duguid, G I Murray, F J Gilbert, A Denison, F Mckiddie, T Ahearn, I Fleming, J Leeds, P Phull, K Park, S Nanthakumaran, H I Grabsch, P Tan, A Welch, L Schweiger, A Dahle-Smith, G Urquhart, M Finegan and R D Petty Br J Cancer 2014 110: 1525-1534; advance online publication, February 25, 2014; 10.1038/bjc.2014.45 Abstract | Full Text Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity M J M Gooden, V R Wiersma, A Boerma, N Leffers, H M Boezen, K A ten Hoor, H Hollema, A M E Walenkamp, T Daemen, H W Nijman and E Bremer Br J Cancer 2014 110: 1535-1544; advance online publication, February 11, 2014; 10.1038/bjc.2014.55 Abstract | Full Text TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients M J Pajares, J Agorreta, E Salvo, C Behrens, I I Wistuba, L M Montuenga, R Pio and A Rouzaut Br J Cancer 2014 110: 1545-1551; advance online publication, January 30, 2014; 10.1038/bjc.2014.33 Abstract | Full Text High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment G-F Ma, Q Miao, Y-M Liu, H Gao, J-J Lian, Y-N Wang, X-Q Zeng, T-C Luo, L-L Ma, Z-B Shen, Y-H Sun and S-Y Chen Br J Cancer 2014 110: 1552-1560; advance online publication, February 18, 2014; 10.1038/bjc.2014.47 Abstract | Full Text Human papillomavirus, p16INK4A, and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina K Hellman, D Lindquist, C Ranhem, E Wilander and S Andersson Br J Cancer 2014 110: 1561-1570; advance online publication, February 13, 2014; 10.1038/bjc.2014.32 Abstract | Full Text RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis K Tsuta, T Kohno, A Yoshida, Y Shimada, H Asamura, K Furuta and R Kushima Br J Cancer 2014 110: 1571-1578; advance online publication, February 6, 2014; 10.1038/bjc.2014.36 Abstract | Full Text Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study M H Uijterwaal, B I Witte, F J Van Kemenade, D Rijkaart, R Ridder, J Berkhof, G A M A Balfoort-van der Meij, M C G Bleeker, P J F Snijders and C J L M Meijer Br J Cancer 2014 110: 1579-1586; advance online publication, February 11, 2014; 10.1038/bjc.2014.34 Abstract | Full Text Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review C Grønhøj Larsen, M Gyldenløve, D H Jensen, M H Therkildsen, K Kiss, B Norrild, L Konge and C von Buchwald Br J Cancer 2014 110: 1587-1594; advance online publication, February 11, 2014; 10.1038/bjc.2014.42 Abstract | Full Text Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis Z Mei, Y Liu, C Liu, A Cui, Z Liang, G Wang, H Peng, L Cui and C Li Br J Cancer 2014 110: 1595-1605; advance online publication, February 6, 2014; 10.1038/bjc.2014.46 Abstract | Full Text RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas S Deb, H Xu, J Tuynman, J George, Y Yan, J Li, R L Ward, N Mortensen, N J Hawkins, M J McKay, R G Ramsay and S B Fox Br J Cancer 2014 110: 1606-1613; advance online publication, February 18, 2014; 10.1038/bjc.2014.31 Abstract | Full Text MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients M Pichler, A L Ress, E Winter, V Stiegelbauer, M Karbiener, D Schwarzenbacher, M Scheideler, C Ivan, S W Jahn, T Kiesslich, A Gerger, T Bauernhofer, G A Calin and G Hoefler Br J Cancer 2014 110: 1614-1621; advance online publication, February 6, 2014; 10.1038/bjc.2014.51 Abstract | Full Text Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling A Atrih, M A V Mudaliar, P Zakikhani, D J Lamont, J T-J Huang, S E Bray, G Barton, S Fleming and G Nabi Br J Cancer 2014 110: 1622-1633; advance online publication, February 18, 2014; 10.1038/bjc.2014.24 Abstract | Full Text Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction G T Lee, D I Kang, Y-S Ha, Y S Jung, J Chung, K Min, T H Kim, K H Moon, J M Chung, D H Lee, W-J Kim and I Y Kim Br J Cancer 2014 110: 1634-1644; advance online publication, February 11, 2014; 10.1038/bjc.2014.23 Abstract | Full Text Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells H Hirata, Y Hinoda, V Shahryari, G Deng, Y Tanaka, Z L Tabatabai and R Dahiya Br J Cancer 2014 110: 1645-1654; advance online publication, February 6, 2014; 10.1038/bjc.2014.48 Abstract | Full Text Genetics and Genomics Top Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer S Merson, Z H Yang, D Brewer, D Olmos, A Eichholz, F McCarthy, G Fisher, G Kovacs, D M Berney, C S Foster, H Møller, P Scardino, J Cuzick, C S Cooper and J P Clark on behalf of the Transatlantic Prostate Group Br J Cancer 2014 110: 1655-1662; advance online publication, January 30, 2014; 10.1038/bjc.2014.13 Abstract | Full Text Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease D Leongamornlert, E Saunders, T Dadaev, M Tymrakiewicz, C Goh, S Jugurnauth-Little, I Kozarewa, K Fenwick, I Assiotis, D Barrowdale, K Govindasami, M Guy, E Sawyer, R Wilkinson, The UKGPCS Collaborators, A C Antoniou, R Eeles and Z Kote-Jarai Br J Cancer 2014 110: 1663-1672; advance online publication, February 20, 2014; 10.1038/bjc.2014.30 Abstract | Full Text Host genetic variants of ABCB1 and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia Y Lu, S K Y Kham, H Ariffin, A M I Oei, H P Lin, A M Tan, T C Quah and A E J Yeoh Br J Cancer 2014 110: 1673-1680; advance online publication, January 16, 2014; 10.1038/bjc.2014.7 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.